Cathepsin-binding compounds bound to a carrier and their diagnostic use
The invention relates to Cathepsin-binding compounds bound to a carrier comprising a diagnostic moiety, for use in the diagnosis of inflammatory diseases, and/or for use in the diagnosis of neoplastic diseases, wherein the Cathepsin-binding compound binds to inflammatory cells of the tumour stroma. The invention also relates to Cathepsin B-targeting compounds and Cathepsin B-binding and liposome-binding compounds.
1. A Cathepsin binding and liposome-binding compound having the structure of formula (XIII):
wherein n=38 to 53.
2. A Cathepsin targeting compound, comprising the Cathepsin binding and liposome-binding compound of claim 1 , bound to a liposome.
3. The Cathepsin targeting compound according to claim 2 , comprising a diagnostic moiety.